1-3 of 3
puva therapy
Close
Sort by
Journal Articles

Low-Dose Bexarotene and Phototherapy or Interferon Alfa-2a in the Treatment of Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma

Brady Beltran, MD, Antonio Paredes, MD, Celia Moises, MD, Gadwin Sanchez, MD, Luis Riva, MD, Fernando Hurtado, MD, Renzo Salas, MD, Jorge Castillo, MD
Journal: Blood
Blood (2008) 112 (11): 5010.
https://doi.org/10.1182/blood.V112.11.5010.5010
Published: 2008
Journal Articles

The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy

Sergio Caffieri, Fabio Di Lisa, Federico Bolesani, Monica Facco, Gianpietro Semenzato, Francesco Dall'Acqua, Marcella Canton
Journal: Blood
Blood (2007) 109 (11): 4988–4994.
https://doi.org/10.1182/blood-2006-08-037192
Published: 2007
Journal Articles

Detection of a T Cell Clone in the Peripheral Blood at Diagnosis and in the Skin in Complete Clinical Remission after PUVA and Interferon-α Combination Therapy Is Not a Negative Prognostic Factor in Early Mycosis Fungoides.

Goteri Gaia, MD, Rupoli Serena, MD, Pulini Stefano, MD, Tassetti Angela, MD, Ranaldi Renzo, MD, Scortechini Anna Rita, MD, Capretti Roberta, MD, Filosa Alessandra, MD, Morichetti Doriana, MD, Mulattieri Simonetta, MD, Leoni Pietro, MD
Journal: Blood
Blood (2005) 106 (11): 2820.
https://doi.org/10.1182/blood.V106.11.2820.2820
Published: 2005